Keyword Analysis & Research: imfinzi
Keyword Research: People who searched imfinzi also searched
Search Results related to imfinzi on Search Engine
-
Immunotherapy for BTC, uHCC, NSCLC & ES-SCLC – IMFINZI® …
https://www.imfinzi.com/
WEBIMFINZI® (durvalumab) is an immunotherapy approved to treat patients with unresectable hepatocellular carcinoma, bile duct cancer, gallbladder cancer, unresectable Stage 3 NSCLC, Stage 4 NSCLC, and extensive-stage SCLC.
DA: 45 PA: 33 MOZ Rank: 62
-
Imfinzi: Uses, Dosage, Side Effects & Warnings - Drugs.com
https://www.drugs.com/imfinzi.html
WEBJun 2, 2023 · Imfinzi (durvalumab) is a cancer medicine that works with your immune system to interfere with the growth and spread of cancer cells in the body. Imfinzi is used to treat non-small cell lung cancer (NSCLC), small cell lung cancer, or biliary tract cancer.
DA: 69 PA: 21 MOZ Rank: 85
-
Imfinzi: Side Effects, Use for Lung Cancer, Dosage, and More
https://www.healthline.com/health/drugs/imfinzi
WEBAug 23, 2022 · What is Imfinzi? If you’ve been diagnosed with lung cancer, your doctor may suggest treatment with Imfinzi. Imfinzi is prescribed to treat the following types of lung cancer in adults: small...
DA: 61 PA: 61 MOZ Rank: 26
-
Imfinzi (durvalumab): Side effects, dosage, uses, and more
https://www.medicalnewstoday.com/articles/imfinzi
WEBFeb 7, 2024 · Imfinzi is a brand-name drug that’s prescribed for certain cancers, including some types of lung cancer. Imfinzi contains the active ingredient durvalumab. It’s given as an intravenous (IV)...
DA: 9 PA: 66 MOZ Rank: 15
-
Durvalumab - Wikipedia
https://en.wikipedia.org/wiki/Durvalumab
WEBDurvalumab, sold under the brand name Imfinzi, is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 ( PD-L1 ) with the PD-1 (CD279).
DA: 19 PA: 74 MOZ Rank: 45
-
Treatment for Unresectable Stage 3 NSCLC - IMFINZI
https://www.imfinzi.com/stage-3-nsclc/about/what-is-imfinzi.html
WEBIMFINZI is a prescription medicine used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC). IMFINZI may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same time ...
DA: 9 PA: 64 MOZ Rank: 82
-
What is IMFINZI® (durvalumab) – Treatment for ES-SCLC
https://www.imfinzi.com/small-cell-lung-cancer/about/what-is-imfinzi.html
WEBIMFINZI ® (durvalumab) is a prescription medicine that works with the immune system to help the body fight cancer. It is used to treat extensive-stage small cell lung cancer (ES-SCLC) in combination with chemotherapy. IMFINZI may also attack healthy cells. WHAT’S THE NEXT STEP?
DA: 46 PA: 28 MOZ Rank: 78
-
IMFINZI® (durvalumab) significantly improved overall survival and
https://www.astrazeneca-us.com/media/press-releases/2024/imfinzi-significantly-improved-overall-survival-and-progression-free-survival-for-patients-with-limited-stage-small-cell-lung-cancer-in-adriatic-phase-III-trial.html
WEBApr 5, 2024 · IMFINZI is also the only approved immunotherapy and the global standard of care in the curative-intent setting of unresectable, Stage III non-small cell lung cancer (NSCLC) in patients whose disease has not progressed after CRT based on the PACIFIC Phase III trial. IMPORTANT SAFETY INFORMATION.
DA: 53 PA: 65 MOZ Rank: 46
-
Imfinzi - Side Effects, Interactions, Uses, Dosage, Warnings
https://www.everydayhealth.com/drugs/imfinzi
WEBWhat is Imfinzi (Intravenous) used for? Non-Small Cell Lung Cancer. Small Cell Lung Cancer. Urothelial Carcinoma. warnings. What is the most important information I should know about Imfinzi...
DA: 46 PA: 9 MOZ Rank: 63
-
Imfinzi | European Medicines Agency
https://www.ema.europa.eu/en/medicines/human/EPAR/imfinzi
WEBOverview. Imfinzi is a medicine used to treat lung cancer. It is for use in adults with:
DA: 8 PA: 79 MOZ Rank: 79